Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07448623) titled 'A Research Study to Look at the Distribution and Effects of Coramitug on Amyloid Deposits in Heart Tissue Using PET/CT Imaging in People With ATTR Amyloidosis' on Feb. 26.
Study Type: Interventional
Study Design:
Allocation: Non-Randomized. Intervention model: Sequential Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Novo Nordisk A/S
Condition:
Transthyretin Amyloid Cardiomyopathy
Intervention:
Drug: Coramitug
Recruitment Status: Not recruiting
Phase: Phase 1
Date of First Enrollment: March 2, 2026
Target Sample Size: 14
Countries of Recruitment:
Netherlands
To k...